Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-10 Purchase |
2025-04-14 6:57 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
20,000 | $5.08 | $101,600 | 1,198,918 (Indirect Direct) |
View |
| 2025-02-21 Sale |
2025-02-25 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
16,303 | $10.58 | $172,486 | 1,178,918 (Indirect Direct) |
View |
| 2024-11-21 Sale |
2024-11-25 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
11,091 | $13.05 | $144,782 | 1,113,566 (Indirect Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 4:26 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
9,650 | $18.5 | $178,564 | 1,124,657 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 4:33 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
9,790 | $23.35 | $228,597 | 1,317,757 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
20,272 | $29.84 | $604,876 | 1,223,913 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,767 | $15.47 | $73,750 | 931,092 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:27 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
12,194 | $19.06 | $232,418 | 536,885 (Direct) |
View |
| 2022-02-07 Purchase |
2022-02-08 4:43 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
22,000 | $17.34 | $381,513 | 923,877 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
325,000 | $0 | 1,438,566 (Direct) |
View |
| 2022-02-14 Other |
2024-05-20 4:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
91,725 | $0 | 1,317,757 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-20 4:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
17,662 | $0 | 1,317,757 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
262,913 | $0 | 1,223,913 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
93,656 | $0 | 1,090,659 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 7:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 978,969 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 983,736 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 7:01 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Shah Gaurav Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:04 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 987,858 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
31,440 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
464,907 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
464,907 | $0 | 464,907 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:16 pm |
N/A 2032-06-08 |
Talaris Therapeutics Inc. | TALS | Shah Gaurav Director |
14,501 | $0 | 14,501 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-16 9:02 pm |
N/A 2032-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
392,312 | $0 | 392,312 (Direct) |
View |
Ownership |
2021-05-06 9:18 pm |
N/A 2030-12-04 |
Talaris Therapeutics Inc. | TALS | Shah Gaurav Director |
0 | $0 | 76,635 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-01 9:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,493 | $45.94 | 901,877 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-01 9:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,475 | $47.21 | 901,877 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-01 9:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
8,872 | $46.45 | 901,877 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-01 9:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
5,919 | $45.21 | 901,877 (Direct) |
View |
| 2021-03-30 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
8,505 | $44.34 | 931,636 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
3,000 | $45.59 | 931,636 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
23,003 | $45.06 | 931,636 (Direct) |
View |
| 2021-03-30 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
19,984 | $41.8 | 931,636 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
75,880 | $1.69 | 931,636 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
61,350 | $44.24 | 931,636 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-01 9:08 pm |
N/A 2027-04-12 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
75,880 | $0 | 931,636 (Direct) |
View |
| 2021-03-30 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
8,667 | $42.8 | 931,636 (Direct) |
View |
| 2021-03-30 Tax Withholding |
2021-04-01 9:08 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
48,732 | $43.86 | 931,636 (Direct) |
View |
| 2020-12-09 Ownership |
2021-02-16 9:55 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO |
406,238 | $0 | 821,100 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 8:41 pm |
N/A 2031-02-03 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav President & CEO |
185,000 | $0 | 185,000 (Direct) |
View |